Oakleaf Care (Hartwell) Limited

Advice on the sale of Oakleaf Care (Hartwell) Limited to CareTech Holdings PLC.

Gettyimages 697853664 WEB
Published: 14 Mar 2016 Updated: 13 Apr 2022

Smith & Williamson acted as lead corporate finance advisor to award winning acquired brain injury rehabilitation provider Oakleaf Care on its sale to CareTech Holdings Plc.

Oakleaf Care (Hartwell) Ltd (“Oakleaf”) provides brain injury rehabilitation to adult males requiring specialist care and long-term support. CareTech Holdings Plc (“CareTech”) is a provider of specialist social care services in the UK, supporting adults and children with a wide range of complex needs across more than 250 specialist services.

Based in Northamptonshire, the Group operates over 80 beds across a number of sites, with highly trained staff, providing a seamless rehabilitation pathway of care for men with acquired brain injury. Oakleaf prides itself on helping patients maximise their potential through individually designed care packages that seek to increase independence and enhance quality of life.

The business continues to expand, with a new 22 bed care home opening this quarter bringing the total to over 100 beds. The acquisition gives CareTech a presence in ABI rehabilitation enabling it to offer additional pathways to its client care group.

Brian Livingston, Managing Director and Head of Mergers & Acquisitions at Smith & Williamson, assisted by Christian Schosland and Stuart Goodman, led Smith & Williamson’s Corporate Finance team on this transaction. This is the 68th deal that the healthcare team of M&A International have completed since 2014.
Ian Mosely, Chief Executive of Oakleaf said: “I would like to thank Smith & Williamson for helping us navigate the sale process. They understood that we had never undertaken a project of this nature before and explained and consulted with us on each step of the way. They also understood the importance of our core philosophy; providing the best level of care to patients.”

Jeremy and Jackie Hunt, Directors of Oakleaf added: “The result would not have been achieved without Brian Livingston and his team at Smith & Williamson, who provided pro-active and unstinting support throughout this transaction including on a number of difficult elements. Their in depth health care sector knowledge and experience added real value to achieving a successful sale“.

Brian Livingston, Managing Director and Head of Mergers & Acquisitions at Smith & Williamson commented: “We are totally thrilled to have been able to deliver this transaction for both the shareholders and the on-going management team. This deal recognises the shareholders hard work over the last 10 years and brings even more opportunities for the future. Smith & Williamson has a strong track record within the care industry and we were pleased to be able to work with a business like Oakleaf which has such a strong culture of care.”

For further information please contact:

Brian Livingston
Tel: 020 7131 4914

Stuart Goodman
T: 020 7131 4999
E: stuart.goodman@smithandwilliamson.com

By necessity, this briefing can only provide a short overview and it is essential to seek professional advice before applying the contents of this article. No responsibility can be taken for any loss arising from action taken or refrained from on the basis of this publication. Details correct at time of writing.

Note to editors
Smith & Williamson is an independently owned professional and financial services group with over 1,700 people. The group is a leading provider of investment management, financial advisory and accountancy services to private clients, professional practices and mid-to-large corporates. The group has eleven offices; these are in London, Belfast, Birmingham, Bristol, Dublin (City and Sandyford), Glasgow, Guildford, Jersey, Salisbury and Southampton.

Smith & Williamson Corporate Finance Limited
Authorised and regulated by the Financial Conduct Authority. A member of Oaklins International Inc. For legal notices, please refer www.oaklins.com/legal.


This article was previously published on Smith & Williamson prior to the launch of Evelyn Partners.